Consistent with these findings, we previously performed a combined analysis of MRE11 and ATM expression in a cohort of 262 rectal cancer patients, which revealed that elevated expression of these proteins in the tumor center is a predictive marker for OS and DFS, as well as poor response to neoadjuvant radiotherapy [28]. This evidence concerns the gene MRE11 and rectal cancer.